Link Check results for patientalnalogworking.pages.dev

No Security Risks Detected

This domain appears to be safe and secure

100%

Score

Disclaimer: This assessment is based on automated analysis of publicly available information. Results are for informational purposes only. For critical applications, consult security professionals.

Scan Information

Last checked:January 5, 2026 00:11:18

Target URL:https://patientalnalogworking.pages.dev/

Scan Complete

Refresh page after 10 minutes
for updated results

Page Information

Target URL

https://patientalnalogworking.pages.dev/

Page Title

The Patient Analog - Scientific Framework for Human Simulation Technologies

Site Favicon

Status

Active

Host Information

Domain

patientalnalogworking.pages.dev

Server

cloudflare

Country

United States

IP Address

172.66.44.165

ASN Information

13335

CLOUDFLARENET

Technologies

Three.js

JavaScript graphics

HSTS

Security

cdnjs

CDN

Cloudflare

CDN

HTTP/3

Miscellaneous

SSL Certificate

HTTPS Enabled

Secure

Certificate Issuer

WE1

Valid From

2026-01-02 23:11:05

Valid Until

2026-04-03 00:09:55

Subject Name

patientalnalogworking.pages.dev

Performance Statistics

Total Requests

Domains

IP Addresses

14.08 MB

Transfer Size

Content Size14.94 MB

HTTP Headers

access-control-allow-origin

alt-svc

h3=":443"; ma=86400

cache-control

public, max-age=0, must-revalidate

cf-ray

9b8ec2292dc6c3a0-SEA

content-encoding

content-security-policy

default-src 'self'; script-src 'self' 'unsafe-inline' 'unsafe-eval' https://cdnjs.cloudflare.com https://unpkg.com https://fonts.googleapis.com https://static.cloudflareinsights.com blob:; script-src-elem 'self' 'unsafe-inline' https://cdnjs.cloudflare.com https://unpkg.com https://fonts.googleapis.com https://static.cloudflareinsights.com; style-src 'self' 'unsafe-inline' https://fonts.googleapis.com https://cdnjs.cloudflare.com; font-src 'self' https://fonts.gstatic.com data:; img-src 'self' data: https: blob:; connect-src 'self' https://cdnjs.cloudflare.com https://unpkg.com https://fonts.googleapis.com https://fonts.gstatic.com https://cloudflareinsights.com; media-src 'self' blob:; object-src 'none'; base-uri 'self'; form-action 'self' mailto:; worker-src 'self' blob:; child-src 'self' blob:

content-type

text/html; charset=utf-8

date

Mon, 05 Jan 2026 00:11:27 GMT

etag

W/"1d7130598e9f9147d4a22b500737f003"

nel

{"report_to":"cf-nel","success_fraction":0.0,"max_age":604800}

permissions-policy

accelerometer=(), camera=(), geolocation=(), gyroscope=(), magnetometer=(), microphone=(), payment=(), usb=(), xr-spatial-tracking=(self)

referrer-policy

strict-origin-when-cross-origin

report-to

{"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=gV3ZTMmAxhmHaZmRHb0y0%2BsHnokxlYjBPKS1Bk3PHoSu7A7QwNOvTsVedqiAhevAb17juFrzKH7qx4Pt0pHVNJ52cSeGBlWz9giaS76b7sCyfBh6XI92IqCH8aOeFBOg%2FZjADhQsusCpHQ8%3D"}]}

server

cloudflare

vary

accept-encoding

x-content-type-options

nosniff

x-frame-options

SAMEORIGIN

x-xss-protection

1; mode=block

18 headers detected

Technology Stack Analysis

Three.js

JavaScript graphics

Three.js is a cross-browser JavaScript library and application programming interface used to create and display animated 3D computer graphics in a web browser using WebGL.

HSTS

Security

HTTP Strict Transport Security (HSTS) informs browsers that the site should only be accessed using HTTPS.

cdnjs

CDN

cdnjs is a free distributed JS library delivery service.

Cloudflare

CDN

Cloudflare is a web-infrastructure and website-security company, providing content-delivery-network services, DDoS mitigation, Internet security, and distributed domain-name-server services.

HTTP/3

Miscellaneous

HTTP/3 is the third major version of the Hypertext Transfer Protocol used to exchange information on the World Wide Web.

External Links 524

S.5002 - FDA Modernization Act 2.0 | Congress.gov

www.congress.gov

No Security Risks Detected

Scan Information

Page Information

Host Information

Technologies

SSL Certificate

Performance Statistics

HTTP Headers

Technology Stack Analysis

Three.js

HSTS

cdnjs

Cloudflare

HTTP/3

External Links 524

S.5002 - FDA Modernization Act 2.0 | Congress.gov

FDADecember 201621st Century Cures Act Established Drug Development Tool Qualification Program and ISTAND Pilot. First acceptance: Emulate Liver-Chip S1 (September 2024).

Tissue Chip Program | NCATS NIH

CATALYST Program - Drug Safety Models | ARPA-H

Microphysiological Systems Program | DARPA

EPA2019-2035NAMs Strategic Roadmap New Approach Methodologies roadmap targeting 30% reduction in mammalian testing by 2025, complete elimination by 2035.

EMASeptember 20213Rs Initiative European Medicines Agency free Innovation Task Force consultations for New Approach Methodologies developers.

OECDOngoingTest Guideline Program First international non-animal skin sensitization standard (TG 497). 56 new alternative testing guidelines published June 2025.

UK2004-PresentNC3Rs Program National Centre for the 3Rs. £15.9M awarded November 2025 for human in vitro model development.

CHINA NMPA2024NAMs Approval& National OoC Standard 11 alternative methods approved March 2024. First national organ-on-chip standard published November 2024.

JAPAN PMDAOngoingAlternative Methods Initiative Pharmaceutical and Medical Devices Agency advancing organoid and MPS acceptance for regulatory submissions.

SAUDI ARABIA2021-2040Vision 2030 Healthcare $3.9B biotech R&D since 2021, targeting $34.6B by 2040. King Faisal Hospital gene/cell therapy facility opened October 2025.

S.355 - FDA Modernization Act 3.0 | Congress.gov

H.R.2821 - FDA Modernization Act 3.0 | Congress.gov

Senate Clears FDA Modernization Act 3.0 | Drug Discovery Trends

Senator Schmitt's FDA Modernization Act 3.0 | Senate.gov

U.S. Senate Passes FDA Modernization Act 3.0 | Animal Wellness Action

FDA Modernization Act Fact Sheet | ModernizeTesting.org

Industry Perspective on FDA Mod Act 2.0/3.0 | PubMed NIH

Sponsors' Next Steps to Reduce Animal Use | Toxicological Sciences

FDA Modernization Act 2.0 Allows Alternatives | PubMed

Transitioning Beyond Animal Models | PMC

A New Path to New Drugs | Science AAAS

FDA Pushes to Replace Animal Testing | Nature Biotechnology

Drug Testing in Animals Rendered Optional | American Journal of Medicine

Passage of Senate Bill S.5002 | Covington& Burling LLP

FDA Mod Act 2.0: The Challenge Our Industry Needs | Halloran

What Has Changed in US Regulations? | EARA

H.R.34 - 21st Century Cures Act | Congress.gov

Drug Development Tool Qualification Programs | FDA

21st Century Cures Act: Key Provisions | Covington

Proposed FDA Work Plan for 21st Century Cures | FDA

CDER Streamlined Nonclinical Studies& NAMs | FDA

Implementing Alternative Methods | FDA

Advancing Alternative Methods at FDA | FDA

Replacing and Reducing Animal Testing at CDER | FDA

Roadmap to Reducing Animal Testing | FDA

FDA Announces Plan to Phase Out Animal Testing | FDA

FDA ISTAND Pilot Program - Organ-on-a-Chip | FDA

Nonclinical Safety Evaluation Guidance | FDA

FDA Initiative& Sponsors' Opportunities | Parexel

First FDA IND Milestone Using Human Vascularized Organoid | Fierce Biotech

Investigational New Drug (IND) Application | FDA

IND Applications: Pharmacology& Toxicology | FDA

What Is IND-Enabling Testing? | WuXi AppTec

IND-Enabling Studies | Charles River

Key IND-Enabling Studies Required | Allucent

EMA 3Rs Initiative - Minimise Animal Testing | EMA

OECD Test Guideline 497 - Defined Approaches | OECD

ICH S9 Nonclinical Evaluation Guidelines | ICH

CRACK IT Challenges - £2.1M Funding | NC3Rs

EMA New Measures to Minimise Animal Testing | Drug Target Review

EMA Encourages Use of NAMs | PharmTech

New Approach Methodologies (NAMs) | EPA

Strategic Vision for NAMs - Metrics | EPA

EPA NAMs Work Plan - Reducing Animal Use | EPA

NAMs Training | EPA

Roadmap to Reduce Animal Testing – EU vs US | Frontiers

Tissue Chip Projects& Initiatives | NCATS

Tissue Chips in Space | NCATS

Tissue Chip Collaborations& Partnerships | NCATS

NIH-Funded Centers - FDA-Ready Tools | NCATS

Tissue Chip for Drug Screening | NCATS

Biological Technologies Office (BTO) | DARPA

DARPA& NIH Fund Human Body on Chip | MIT News